Dinali Wijewarnasuriya

Dinali Wijewarnasuriya is currently working as a Principal Scientist at Serotiny. Prior to this role, Dinali held positions as Senior Scientist II at Allogene Therapeutics, Senior Scientist at Boehringer Ingelheim, and as a Postdoctoral Fellow at Memorial Sloan Kettering Cancer Center where Dinali completed their PhD in the laboratory of Dr. Renier Brentjens. Dinali also has experience as the President of Bench to Bedside Initiative and as Co-Director of External Affairs at TRIBC Biotech Club. Additionally, Dinali has served as a Teaching Assistant at both Bench to Bedside Initiative and UCLA. Dinali holds a Bachelor's degree in Molecular Cell and Developmental Biology from UCLA and a Doctor of Philosophy in Oncology and Cancer Biology from Weill Cornell Graduate School of Medical Sciences.